221. Analysis of the incidence of post-cholecystectomy diarrhea and its influencing factors in Hainan Province.
作者: Fengjiao Mao.;Daya Zhang.;Xianfeng Huang.;Da Li.;Wenrui Chen.;Fan Zeng.;Chen Chen.;Shimei Huang.;Yanting Lv.;Yuliang Huang.;Runyu Chen.;Ying Mo.;Qiuli Nie.;Shuo Zhou.;Xiaodong Zhang.;Qicen Yao.;Yiping Du.;Bo Ran.;Yan Tan.;Na Liu.;Yunqian Xie.;Feihu Bai.
来源: BMC Gastroenterol. 2025年25卷1期244页
Cholecystectomy is one of the most common surgical procedures for the treatment of diseases associated with gallstones, and the incidence of post-cholecystectomy diarrhea (PCD) has attracted attention in recent years. The aim of this study was to assess the prevalence of PCD in patients with gallstones and to analyze the factors influencing it.
222. The effectiveness of treatment with probiotics in preventing necrotizing enterocolitis and related mortality: results from an umbrella meta-analysis on meta-analyses of randomized controlled trials.
作者: Jiaju Han.;Yufeng Ren.;Peini Zhang.;Chengfeng Fang.;Leilei Yang.;Shenkang Zhou.;Zhiqing Ji.
来源: BMC Gastroenterol. 2025年25卷1期245页
Probiotic supplementation has been proposed as a preventive measure for necrotizing enterocolitis (NEC) in preterm infants. This umbrella meta-analysis assesses the effects of probiotics, including single-strain and multi-strain formulations, on NEC and related mortality.
223. Comparing surgical and conservative treatment approaches for perianal abscess in patients with hematologic malignancies: a comprehensive analysis.
Perianal abscess (PA) is a complication of infection in patients with hematologic malignancies. However, the simultaneous occurrence of neutropenia and increased susceptibility to bleeding pose significant challenges for surgical intervention in perianal abscesses. In this retrospective study, we sought to evaluate and compare the efficacy of pharmacological therapy and surgical intervention in the management of PA in patients with hematologic malignancies, bwtween 2015 and 2022 at the Fujian Medical University Union Hospital. In total, 53 patients were enrolled in this study, including 19 cases with surgical intervention, and 34 cases with conservative treatment. During the 60-day follow-up period, a significant improvement of symptoms or complete resolution was observed in 48 patients (90.5%). But the cure rates between the two groups showed no significant difference (p > 0.05). Additionally, the surgical group demonstrated a significantly lower recurrence rate compared to the conservative group, while there was no statistically significant disparity in recurrence rates (10.4% vs. 23.6%, p > 0.05). Patients with conservative treatment showed significantly shorter recovery time compared to patients with surgical treatment (p = 0.048). In conclusion, both conservative and surgical management approaches were safe and effective in relieving symptoms, but surgical intervention significantly decreased the recurrence rate. Therefore, consideration of surgical intervention is warranted for patients with recurrent perianal infections after conservative treatment.
224. Comparative effects of aerobic and resistance exercise on bile acid profiles and liver function in patients with non-alcoholic fatty liver disease.
作者: Jiasen Shi.;Junchao Cui.;Tianlei Zheng.;Xiaoping Han.;Bin Wang.;Wenjing Wang.;Chenggang Zhu.;Chenle Fang.;Xueyan Zhou.;Ning Cong.;Xiaoxing Yin.;Qiang Yang.
来源: BMC Gastroenterol. 2025年25卷1期239页
Our research aims to explore the effects of different exercise on liver function and bile acid in patients with non-alcoholic fatty liver disease (NAFLD), to identify the most beneficial exercise modalities for patients with NAFLD.
225. The impact of KRAS mutations on risk of venous thromboembolism recurrence in patients with metastatic colorectal cancer.
作者: Zhikun Liang.;Xiaoyan Huang.;Jieling Mao.;Jingwen Xie.;Xiaoyan Li.;Li Qin.
来源: BMC Gastroenterol. 2025年25卷1期240页
The relationship between KRAS mutations and the risk of venous thromboembolism (VTE) recurrence in metastatic colorectal cancer (mCRC) patients with established cancer-associated thrombosis (CAT) remains uncertain. This study aims to (1) evaluate the predictive value of seven KRAS mutation subtypes for VTE recurrence and (2) assess the impact of incorporating these mutations into two existing VTE risk scores: the Khorana score and the Ottawa score.
226. The best anthropometric indices to predict colon cancer.
作者: Kaihao Wang.;Anlei Wang.;Shaozu Wang.;Zhijiang Luo.;Yazhao Gong.;Xiaoliang Hao.;Guanglei Yang.;Shuqing Xu.
来源: BMC Gastroenterol. 2025年25卷1期242页
Colon cancer is one of the most prevalent malignancies globally. Anthropometric data are widely accessible. However, numerous anthropometric indicators exist, and no study has identified the most reliable predictor for colon cancer. This study aims to identify the most effective anthropometric indicators for predicting colon cancer.
227. Metabolic score for visceral fat is correlated with all-cause and cardiovascular mortality among individuals with non-alcoholic fatty liver disease.
作者: Chunming Xie.;Xianpei Chen.;Jiakun Zhang.;Xueqing Jiang.;Jing Xu.;Hao Lin.
来源: BMC Gastroenterol. 2025年25卷1期238页
Metabolic score for visceral fat (METS-VF) as an effective marker of visceral obesity has been correlated with non-alcoholic fatty liver disease (NAFLD). This study aims to explore the correlation between METS-VF and both all-cause mortality and cardiovascular disease (CVD)-related mortality among individuals with NAFLD.
228. Correlation and consistency analysis between various indirect portal pressure gradients and actual portal pressure gradient.
作者: Rufeng Chen.;Yaozu Liu.;Li Ma.;Wen Zhang.;Yongjie Zhou.;Minjie Yang.;Jiaze Yu.;Zhiping Yan.;Jingqin Ma.;Jianjun Luo.
来源: BMC Gastroenterol. 2025年25卷1期241页
To evaluate the correlation and consistency between hepatic venous pressure gradient(F-HVPG) calculated as the wedged hepatic venous pressure (WHVP) minus free hepatic venous pressure (FHVP), I-HVPG calculated as WHVP minus inferior vena cava pressure (IVCP) in the hepatic segment, and portal pressure gradient (PPG).
229. Location of endoscopic retrograde cholangiopancreatography impacts fluoroscopy time: a multi-institutional retrospective study at tertiary academic centers.
作者: Daniel Marino.;Kanhai Farrakhan.;Ethan Pearlstein.;Joao Filipe Monteiro.;Sohum Patwa.;Mouhand Mohamed.;Rei Mitsuyama.;Savan Kothadia.;Aastha Chokshi.;Harlan Rich.;Akwi Asombang.
来源: BMC Gastroenterol. 2025年25卷1期243页
Endoscopic retrograde cholangiopancreatography (ERCP) is important in the management of pancreatobiliary diseases and requires fluoroscopy resulting in radiation exposure to those involved. ERCP is performed in different hospital settings such as the endoscopy unit (EU), radiology suite (RS), and operating room (OR) depending on numerous factors. Our study examines the differences in duration of fluoroscopy time (FT) as a surrogate for radiation dosages between multiple unique settings.
230. Therapeutic Targeting of Oncogene-induced Transcription-Replication Conflicts in Pancreatic Ductal Adenocarcinoma.
作者: Shanna J Smith.;Fan Meng.;Robert G Lingeman.;Caroline M Li.;Min Li.;Galyah Boneh.;Toni T Seppälä.;Thuy Phan.;Haiqing Li.;Richard A Burkhart.;Vishwas Parekh.;Syed Rahmanuddin.;Laleh G Melstrom.;Robert J Hickey.;Vincent Chung.;Yilun Liu.;Linda H Malkas.;Mustafa Raoof.
来源: Gastroenterology. 2025年
Transcription-replication conflicts (TRCs) are a key source of replication stress in cancer, with pancreatic ductal adenocarcinoma (PDAC) showing uniquely high levels. This study investigated the mechanism, oncogene dependency, subtype specificity, and preclinical activity of the TRC-targeting molecule AOH1996 in PDAC models. Initial clinical evidence of AOH1996 activity in patients with PDAC is also provided.
231. Preventive Effect of Helicobacter pylori Treatment on Gastric Cancer Incidence and Mortality: A Korean Population Study.
Helicobacter pylori (H pylori) infection is a major risk factor for gastric cancer (GC); however, whether H pylori eradication (HPE) benefits the older population remains unclear. We compared GC incidence and mortality between H pylori-treated individuals and the general population, stratified by age.
232. Clinical practice guidelines for the diagnosis of constipation-predominant irritable bowel syndrome and functional constipation in adults: a scoping review.
作者: Jingyuan Luo.;Wing Lam Wendy To.;Qianqian Xu.;Jialing Zhang.;Yanfang Ma.;Sen Chow.;Danny J Yu.;Chun-Su Yuan.;Zhaoxiang Bian.
来源: BMC Gastroenterol. 2025年25卷1期234页
Constipation-predominant irritable bowel syndrome (IBS-C) and functional constipation (FC) are prevalent disorders with overlapping and fluctuating symptoms, which pose challenges for accurate diagnosis. This study aimed to assess the consistency of diagnostic criteria for IBS-C and FC in adults across clinical practice guidelines (CPGs).
233. An artificial intelligence model utilizing endoscopic ultrasonography for differentiating small and micro gastric stromal tumors from gastric leiomyomas.
作者: Ruifeng Duan.;Liwei Duan.;Xin Chen.;Min Liu.;Xiangyi Song.;Lijuan Wei.
来源: BMC Gastroenterol. 2025年25卷1期237页
Gastric stromal tumors (GSTs) and gastric leiomyomas (GLs) represent the primary subtypes of gastric submucosal tumors (SMTs) characterized by distinct biological characteristics and treatment modalities. The accurate differentiation between GSTs and GLs poses a significant clinical challenge. Recent advancements in artificial intelligence (AI) leveraging endoscopic ultrasonography (EUS) have demonstrated promising results in the categorization of larger-diameter SMTs (> 2.0 cm). However, the diagnostic capacity of AI models for micro-diameter SMTs (< 1.0 cm) remains uncertain due to limited imaging features. This study seeks to develop a specialized diagnostic model utilizing EUS images to differentiate small and micro GSTs from GLs effectively.
234. The fasting plasma glucose to high-density lipoprotein cholesterol ratio: a novel index for identifying NAFLD.
作者: Changhui Yu.;Shiming He.;Nan Peng.;Maobin Kuang.;Xin Huang.;Chao Wang.;Guotai Sheng.;Wei Wang.;Guobo Xie.;Yang Zou.
来源: BMC Gastroenterol. 2025年25卷1期236页
Previous research has indicated that the fasting plasma glucose to high-density lipoprotein cholesterol ratio (FHR) is a novel biomarker for assessing cardiovascular disease prognosis. The objective of this study is to investigate the potential relationship of FHR with non-alcoholic fatty liver disease (NAFLD).
235. Single-cell transcriptomic analysis reveals prognosis-related stromal signatures that potentiate stratification of patients with extrahepatic cholangiocarcinoma.
作者: Chen Ni.;Rulin Hua.;Yuanyuan Yang.;Jialu Liang.;Wentao Liu.;Linlin Wang.;Xiaohan Yao.;Anqi Li.;Long Yu.;Ruo Feng.;Dekang Lv.;Zhihai Qin.;Wenlong Zhai.
来源: BMC Gastroenterol. 2025年25卷1期235页
Extrahepatic cholangiocarcinoma (eCCA) is a rare but refractory cancer with dense desmoplasia. Prognosis-associated stromal cells in eCCA remain poorly characterized. Here, we profiled the tumor cellular composition and identified prognosis-related stromal signatures by single-cell RNA sequencing (scRNA-seq) in eCCA. ECCA patients were further stratified into different categories based on identified stromal signatures.
236. Metabolic Dysfunction-Associated Steatohepatitis Adipose Tissue Macrophages Secrete Extracellular Vesicles That Activate Liver Fibrosis in Obese Male Mice.
作者: Theresa V Rohm.;Felipe Castellani Gomes Dos Reis.;Karina Cunha E Rocha.;Roi Isaac.;Sean Strayer.;Cairo Murphy.;Gautam Bandyopadhyay.;Hong Gao.;Souradipta Ganguly.;Tram Nguyen.;Jinyue Wang.;John E Youhanna.;David Pack.;Xiao Liu.;Hyun Young Kim.;Ishtiaq Jeelani.;Debanjan Dhar.;Tatiana Kisseleva.;Wei Ying.;Jerrold M Olefsky.
来源: Gastroenterology. 2025年
Given the need for effective interventions in metabolic dysfunction-associated steatohepatitis (MASH), understanding the role of adipose tissue macrophage (ATM)-derived small extracellular vesicles (sEVs) is important. We aimed to evaluate the contribution of MASH-ATM-sEVs to the development of liver fibrosis in obese male mice.
237. Tumor Necrosis Factor-Like Ligand 1A/Death Receptor 3 Signaling Regulates the Generation of Pathogenic T Helper 9 Cells in Experimental Crohn's Disease.
作者: Paola Menghini.;Ludovica F Buttó.;Adrian Gomez-Nguyen.;Natalia Aladyshkina.;Kristine-Ann Buela.;Abdullah Osme.;Ricky Chan.;Hannah L Wargo.;Stefania De Santis.;Giorgos Bamias.;Theresa Pizarro.;Fabio Cominelli.
来源: Gastroenterology. 2025年
Death receptor 3 (DR3) and its ligand, tumor necrosis factor-like ligand 1A (TL1A), regulate the balance between effector and regulatory T cells in inflammatory bowel disease (IBD). Although interleukin 9 (IL9)-secreting T helper 9 (Th9) cells are linked to ulcerative colitis, their role in Crohn's disease (CD) is unclear. We investigated the role of DR3 signaling in Th9 cell differentiation in mouse models of CD-like ileitis and colitis.
238. KRASG12D Cells Override Homeostatic Cell Elimination Mechanisms in Adult Pancreas Via Wnt5a and Cell Dormancy.
作者: Beatriz Salvador-Barbero.;Markella Alatsatianos.;Jennifer P Morton.;Owen J Sansom.;Catherine Hogan.
来源: Gastroenterology. 2025年
The adult pancreas protects against cancer by actively expelling genetically mutated cells. Pancreatic cancer starts with cells carrying KRAS mutations; however, it is not clear how some KRAS mutant cells override cell elimination mechanisms to survive in tissues.
239. Efficacy and safety of PPAR agonists in primary biliary cholangitis: a systematic review and meta-analysis of Randomized Controlled Trials.
作者: Behrad Saeedian.;Nastaran Babajani.;Tannaz Bagheri.;Fatemeh Ojaghi Shirmard.;Seyed Morteza Pourfaraji.
来源: BMC Gastroenterol. 2025年25卷1期230页
Primary biliary cholangitis (PBC) is a chronic, progressive autoimmune liver disease. Some patients with PBC do not adequately respond to Ursodeoxycholic acid (UDCA) as a first-line treatment, putting them at an increased risk of disease progression. Peroxisome Proliferator-Activated Receptor (PPAR) agonists are emerging as promising therapeutic options for PBC. We aim to investigate the efficacy and safety of PPAR agonists in treating PBC patients.
240. High sensitivity C-reactive protein implicates heterogeneous metabolic phenotypes and severity in metabolic dysfunction associated-steatotic liver disease.
作者: Hao Wang.;Junzhao Ye.;Youpeng Chen.;Yanhong Sun.;Xiaorong Gong.;Hong Deng.;Zhiyong Dong.;Lishu Xu.;Xin Li.;Bihui Zhong.
来源: BMC Gastroenterol. 2025年25卷1期231页
Whether include high-sensitivity C-reactive protein (Hs-CRP) in diagnostic flow remains debatable during the updated definition to metabolic dysfunction-associated steatotic liver disease (MASLD) despite systemic inflammation contributes to the disease development and progression. We aimed to identify values of hs-CRP compared to other inflammatory markers derived from routine blood tests in MASLD.
|